The former officials say the agency's plan to revamp how vaccines for flu, Covid and other respiratory viruses are handled ...

Changes to the ways in which the FDA plans to regulate vaccines represent a threat to effective vaccines and public health, ...

Twelve former U.S. FDA commissioners said on Wednesday they were deeply concerned about proposed changes to U.S. vaccine ...

The third quarter earnings season is winding down, and only a handful of major companies have yet to report results. So far, the Q3 earnings season has shown largely solid results. As of Nov. 21, 95% ...

VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA ...

In a New England Journal of Medicine article, the former FDA commissioners wrote they were “deeply concerned” by the top vaccine regulator’s approach to raising the bar for approvals.

A recent memo from an FDA vaccine division director has reignited debate about COVID-19 immunization for children. The ...

Americans’ confidence in the Centers for Disease Control and Prevention has plummeted, according to a 2025 National ...

The "Vaccine Development Companies Landscape: Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis" report has been added to ...

The vaccine advisory committee of the Centers for Disease Control and Prevention is scheduled to meet Dec. 4 and 5. On the ...

Mixed options sentiment in Pfizer (PFE), with shares up 52c, or 2.09%, near $25.68. Options volume relatively light with 73k contracts traded and ...